Analysts Set Expectations for RCKT FY2026 Earnings
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for Rocket Pharmaceuticals in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer anticipates that the biotechnology company will post earnings per share of ($1.66) for the […]
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for Rocket Pharmaceuticals in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer anticipates that the biotechnology company will post earnings per share of ($1.66) for the […]
